11.33
전일 마감가:
$11.73
열려 있는:
$11.76
하루 거래량:
489.73K
Relative Volume:
0.80
시가총액:
$662.15M
수익:
$1.12B
순이익/손실:
$55.30M
주가수익비율:
11.93
EPS:
0.95
순현금흐름:
$-30.30M
1주 성능:
+10.11%
1개월 성능:
+17.53%
6개월 성능:
-40.31%
1년 성능:
-27.23%
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
1209 ORANGE STREET, WILMINGTON
EMBC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
EMBC
Embecta Corp
|
11.33 | 685.53M | 1.12B | 55.30M | -30.30M | 0.95 |
![]()
ISRG
Intuitive Surgical Inc
|
493.95 | 177.75B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
182.94 | 53.11B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
90.15 | 45.44B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
273.50 | 40.35B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
257.76 | 18.95B | 2.90B | 467.20M | 306.90M | 6.37 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-04-10 | 개시 | Mizuho | Neutral |
2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
2023-10-20 | 개시 | Wolfe Research | Peer Perform |
2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
2022-09-08 | 개시 | BTIG Research | Neutral |
2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
Why is Embecta Corp. stock attracting strong analyst attentionAchieve rapid portfolio growth with expert help - jammulinksnews.com
Is Embecta Corp. a growth stock or a value stockSuperior portfolio returns - jammulinksnews.com
What are the latest earnings results for Embecta Corp.High-octane investment gains - jammulinksnews.com
Should I hold or sell Embecta Corp. stock in 2025Get timely advice on market trends - jammulinksnews.com
Why Embecta Corp. stock attracts strong analyst attentionRisk Controlled Trading Ideas - metal.it
What analysts say about Embecta Corp. stockSuperior return velocity - PrintWeekIndia
Should I buy Embecta Corp. stock before earningsRecord-setting profit potential - jammulinksnews.com
Is Embecta Corp. a good long term investmentDynamic portfolio growth - PrintWeekIndia
What drives Embecta Corp. stock priceAccelerated financial growth - Autocar Professional
Embecta Corp to Host Conference Call Discussing Q3 2025 Financial Results and Operational Updates - Nasdaq
embecta to Report Fiscal Third Quarter 2025 Financial Results - GlobeNewswire
Embecta Earnings Call: Medical Supply Leader to Present Q3 Results and Strategic Updates - Stock Titan
Diabetes Care Market is evolving rapidly Through 2025 To 2032 | Medtronic, Abbott, Pumps It, Inc., Embecta Corp - openPR.com
Embecta Corp. Stock Analysis and ForecastGame-changing capital returns - Autocar Professional
(EMBC) Technical Data - news.stocktradersdaily.com
BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating - MSN
Mizuho Lowers PT on Embecta Corp. (EMBC) to $13 From $15, Keeps a Neutral Rating - MSN
Is Embecta Corp. a Contrarian Gem in a World Obsessed with Energy? - AInvest
13 Cheap Stocks with Huge Upside Potential - Insider Monkey
How to Take Advantage of moves in (EMBC) - news.stocktradersdaily.com
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):